VISEN Pharmaceuticals 維昇藥業
Please note that due to the planned shutdown of Webb-site.com,
the directors, officers and advisers of HK-listed companies have ceased to be updated effective 2025-03-31. Appointments
and resignations effective on or before that date were recorded, as were advisers recorded in annual reports
filed on or before that date. A repository of our database and software is
now available.
Main board
Name | ⚥ | Age in 2023 |
Position | From | Until | |
---|---|---|---|---|---|---|
1 | Cao, Yibo 曹弋博 | M | 40 | NEDNon-Executive Director | 2021-01-08 | |
2 | Chan, Peng Kuan 陳炳鈞 | M | 60 | INEDIndependent Non-Executive Director | 2021-04-01 | |
3 | Dong, Dandan (1984) 董丹丹 | F | 39 | EDExecutive Director | 2018-11-07 | 2023-12-13 |
4 | Fu, Shan 付山 | M | 55 | NEDNon-Executive Director | 2018-11-01 | |
5 | Jensen, Michael Wolff | M | 52 | NED, ChNon-Executive Director, Chairman | 2021-01-08 | |
6 | Lu, Anbang 盧安邦 | M | 56 | CEOChief Executive Officer | 2018-11-07 | |
7 | Mikkelsen, Jan Møller | M | 64 | NEDNon-Executive Director | 2018-11-07 | |
8 | Ni, Hope Hong 倪虹 | F | 51 | INEDIndependent Non-Executive Director | 2021-04-01 | |
9 | Yao, Zhengbin | M | 57 | INEDIndependent Non-Executive Director | 2021-04-01 |
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy